Menovar: Announcement of Ningbo Menohua Pharmaceutical Co., Ltd. on changing the sponsor representative for continuous supervision
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on changing the sponsor representative for continuous supervision
Menovar: Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the 2025 Interest Payment of “Mino Bonds”
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the 2025 Interest Payment of “Minuo Bonds”
Menovar: Inspection opinions of the board of supervisors of Ningbo Menohua Pharmaceutical Co., Ltd. on matters related to the 9th meeting of the 5th Supervisory Committee
Menovar: Announcement on the lifting of sales restrictions and listing of restricted stocks during the third sales restriction period granted for the first time in the 2021 Stock Options and Restricted Stock Incentive Plan of Ningbo Menova Pharmaceutical Co., Ltd.
Minovar: Legal Opinions of Shanghai Guangfa Law Firm on matters relating to Ningbo Menohua Pharmaceutical Co., Ltd.\'s 2021 Stock Options and Restricted Stock Incentive Plan
Menovar: Ningbo Menohua Pharmaceutical Co., Ltd. Convertible Debt-to-Stock Exchange Results and Stock Change Announcement
Menovar: Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options Incentive Plan for the fourth quarter of 2024 independent exercise results and share changes
Ningbo Menova Pharmaceutical Co., Ltd. Convertible debt-to-share conversion results and share change announcement
Inspection opinions of the board of supervisors of Ningbo Menova Pharmaceutical Co., Ltd. on matters related to the 9th meeting of the 5th Supervisory Committee
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on independent exercise results and share changes for the fourth quarter of 2024 of the 2021 Stock Options Incentive Plan
Announcement on the lifting of sales restrictions and listing of restricted stocks during the third sales restriction period granted for the first time in the 2021 Stock Options and Restricted Stock Incentive Plan of Ningbo Menova Pharmaceutical Co., Ltd.
Legal opinion of Shanghai Guangfa Law Firm on matters relating to Ningbo Menova Pharmaceutical Co., Ltd.\'s 2021 stock options and restricted stock incentive plan
Menovar: An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options and Restricted Stock Incentive Plan to reserve and grant stock options to commence the second exercise period during the second exercise period
An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the 2021 Stock Options and Restricted Stock Incentive Plan to reserve the grant of stock options to commence the exercise of the second exercise period
Announcement of Resolutions of the 10th Meeting of the Fifth Board of Directors of Ningbo Menova Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 10th Meeting of the Fifth Board of Supervisors of Ningbo Menova Pharmaceutical Co., Ltd.
Announcement of Ningbo Menova Pharmaceutical Co., Ltd. on not revising the “Mino Bonds” conversion price downward
An indicative announcement by Ningbo Menova Pharmaceutical Co., Ltd. on the “Mino Bonds Transfer” expected to meet the conditions for the downward revision of the share conversion price
No Data